Skip to content

Acceptance and Commitment Therapy for Insomnia

Acceptance and Commitment Therapy for Chronic Insomnia in Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04866914
Acronym
ACT-I
Enrollment
227
Registered
2021-04-30
Start date
2021-03-15
Completion date
2023-03-15
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

INSOMNIA, acceptance and commitment therapy, Cognitive behavioral therapy, SLEEP

Brief summary

Insomnia is a frequent complaint and is associated with impairments in physical and psychological health. Although Cognitive-Behavioral Therapy (CBT) demonstrates effective results for insomnia, there are those who do not respond to this type of intervention or present difficulties in adherence. Acceptance and Commitment Therapy (ACT) presents itself as a potentially useful intervention for the treatment of insomnia, for which, instead of focusing on controlling the symptoms, the respective approach focuses on accepting the feelings and thoughts associated, through value-based actions. The aim of this study is to evaluate the effectiveness of ACT for chronic insomnia in adults. Participants will be 150 adults aged between 18 and 59 years, diagnosed with chronic insomnia who will be randomly assigned to the ACT, CBT and wait list (WL) groups. For both groups (ACT and CBT), the intervention will be performed in six group and weekly sessions. Assessments of sleep patterns, insomnia, depression, anxiety, psychological flexibility, acceptance of sleep, beliefs about sleep, personality traits will be performed in the pre-treatment, post-treatment and six-month follow-up. After the intervention is completed, participants will respond to an inventory of compliance and satisfaction. Treatment effects will assessed using the fixed effects of group variables (ACT vs. CBT-I and ACT vs. waitlist) and their interaction with time (pre-test vs. post-test and pretest vs. six-month follow-up). Estimated pairwise contrasts to examine changes across time within groups will be used. Variables will analyzed using generalized mixed models (GMM).

Interventions

ACT-I treatment group: Participants diagnosed with chronic insomnia will receive group treatment. The six sessions will be aimed at psychoeducation about sleep added to the therapeutic processes of acceptance, mindfulness, availability, values, defusion and commitment, used in ACT.

BEHAVIORALCognitive Behavioral Therapy for Insomnia

Active control group CBT-I: Participants diagnosed with chronic insomnia will receive treatment in a group. The six sessions will be aimed at cognitive-behavioral components, such as education and sleep hygiene, stimulus control, sleep restriction and demystification / restructuring of belief beliefs.

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of chronic insomnia

Exclusion criteria

* Neurological degenerative disease * Psychotic disorder * sleep apnea, restless legs or periodic limb movements during sleep, or a circadian-based sleep disorder (e.g., delayed or advanced sleep phase syndrome) * cognitive impairments * unavailability in attending the sessions.

Design outcomes

Primary

MeasureTime frameDescription
Change in the score of Insomnia Severity Index (ISI)baseline, 7 weeks and 24 weeks after treatment commencement.Change in the total score of Insomnia Severity Index (ISI)

Secondary

MeasureTime frameDescription
Treatment response - categorical variablebaseline, 7 weeks and 24 weeks after treatment commencement.change or reduction in the ISI total score of 8 points or more
Reduction in Sleep Onset Latency (SOL)baseline, 7 weeks and 24 weeks after treatment commencement.Reduction in Sleep Onset Latency (SOL) measured by sleep diary
Reduction in Wake After Sleep Onset (WASO)baseline, 7 weeks and 24 weeks after treatment commencement.Reduction in Wake After Sleep Onset (WASO) measured by sleep diary
Increase in Total Sleep Time (TST)baseline, 7 weeks and 24 weeks after treatment commencement.Increase in Total Sleep Time (TST) measured by sleep diary
Remission - categorical variablebaseline, 7 weeks and 24 weeks after treatment commencement.a final ISI score under 8 points
Change in the Hospital Anxiety and Depression Scale (HADS)baseline, 7 weeks and 24 weeks after treatment commencement.Change in the total score for the anxiety variable (HADAS-A) and total score for the depression variable (HADAS-D)
Change in the Acceptance and Action Questionnaire-II (AAQ-II)baseline, 7 weeks and 24 weeks after treatment commencement.Change in the the total score of Acceptance and Action Questionnaire-II (AAQ-II)
Change in the Sleep Problem Acceptance Questionnaire (SPAQ)baseline, 7 weeks and 24 weeks after treatment commencement.Change in the the total score of Sleep Problem Acceptance Questionnaire (SPAQ)
Change in the Dysfunctional Beliefs and Attitudes about Sleep (DBAS-16)baseline, 7 weeks and 24 weeks after treatment commencement.Change in the the total score of Dysfunctional Beliefs and Attitudes about Sleep (DBAS-16)
Increase in Sleep Efficiency (SE)baseline, 7 weeks and 24 weeks after treatment commencement.Increase in Sleep Efficiency (SE) measured by sleep diary

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026